Clinical and serological characteristics in 128 patients with systemic lupus erythematosus

被引:16
作者
Ghedira, I [1 ]
Sakly, W [1 ]
Jeddi, M [1 ]
机构
[1] CHU Farhat Hached, Lab Microbiol Immunol, Sousse 4000, Tunisia
来源
PATHOLOGIE BIOLOGIE | 2002年 / 50卷 / 01期
关键词
anticardiolipin antibodies; anti-extractable nuclear antigen antibodies antiphospholipid syndrome; ELISA; systemic lupus erythematosus;
D O I
10.1016/S0369-8114(01)00262-0
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Objective - To analyse the clinical and serological characteristics of systemic lupus erythematosus (SLE) in the center of Tunisia. Methods - We studied 128 patients with SLE aged one to 73 years. Antinuclear antibodies (ANA) were detected by an immunofluorescence method. Anti-double-stranded DNA (anti-dsDNA) antibodies, anti-extractable nuclear antigen antibodies (anti-Sm, anti-SS-A, anti-SS-B and anti-RNP) and anti-cardiolipin (aCL of IgG, IgA and IgM isotypes) antibodies were detected by ELISA. Results - Malar rsah (71%) and anemia (71%) were the most commun clinical manifestations. Arthritis was seen in 62.5%. Severe kidney damage was observed in 39%. Pericarditis and pleuritis were observed in only 23%. Neurological manifestations (16%) were uncommun. Clinical manifestations of anti-phospholipid syndrome (SAPL) were observed in 15%. ANA were detected in 100%, anti-dsDNA in 76%, anti-Sm in 55.5%, anti-SS-A in 64%, anti-SS-B in 33.6%, anti-RNP in 49%. aCL of IgG, IgA and IgM isotypes were detected in 63.5%, 49% and 40.6% of the patients respectively. The only significant positive clinical associations were those of arthritis with anti-dsDNA antibodies (p = 0.022) and malar rash with anti-SS-A antibodies (p = 0.002). Conclusions - This study suggests that tunisians with SLE present, in general, a mild form of disease predominantly manifested by cutaneous, musculoskeletal and hematologic involvement but low prevalence of major organ damage. (C) 2002 Editions scientifiques et medicales Elsevier SAS.
引用
收藏
页码:18 / 24
页数:7
相关论文
共 39 条
[21]  
Margaux J, 1999, REV RHUM, V66, P102
[22]  
Meyer O, 1997, REV PRATICIEN, V47, P821
[23]   Ethnic differences in the clinical expression of systemic lupus erythematosus: A comparative study between African-Americans and Latin Americans [J].
Molina, JF ;
Molina, J ;
Garcia, C ;
Gharavi, AE ;
Wilson, WA ;
Espinoza, LR .
LUPUS, 1997, 6 (01) :63-67
[24]   SYSTEMIC LUPUS-ERYTHEMATOSUS ON THE CARIBBEAN ISLAND OF CURACAO - AN EPIDEMIOLOGIC INVESTIGATION [J].
NOSSENT, JC .
ANNALS OF THE RHEUMATIC DISEASES, 1992, 51 (11) :1197-1201
[25]  
Pahor A, 1998, WIEN KLIN WOCHENSCHR, V110, P338
[26]  
Pan L. T., 1998, Annals Academy of Medicine Singapore, V27, P21
[27]   Significance of the anti-Ro(SS-A) antibody in evaluation of patients with cutaneous manifestations of a connective tissue disease [J].
Provost, TT ;
Watson, R ;
SimmonsOBrien, E .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1996, 35 (02) :147-169
[28]   Utility of anti-Sm, anti-RNP, anti-Ro-SS-A, and anti-La/SS-B (extractable nuclear antigens) detected by enzyme-linked immunosorbent assay for the diagnosis of systemic lupus erythematosus [J].
SanchezGuerrero, J ;
Lew, RA ;
Fossel, AH ;
Schur, PH .
ARTHRITIS AND RHEUMATISM, 1996, 39 (06) :1055-1061
[29]   Psychiatric and psychosocial disorders in patients with systemic lupus erythematosus:: a longitudinal study of active and inactive stages of the disease [J].
Segui, J ;
Ramos-Casals, M ;
García-Carrasco, M ;
de Flores, T ;
Cervera, R ;
Valdés, M ;
Font, J ;
Ingelmo, M .
LUPUS, 2000, 9 (08) :584-588
[30]   100 ANTI-RO (SS-A) ANTIBODY-POSITIVE PATIENTS - A 10-YEAR FOLLOW-UP [J].
SIMMONSOBRIEN, E ;
CHEN, S ;
WATSON, R ;
ANTONI, C ;
PETRI, M ;
HOCHBERG, M ;
STEVENS, MB ;
PROVOST, TT .
MEDICINE, 1995, 74 (03) :109-130